olmesartan has been researched along with carfilzomib in 2 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (carfilzomib) | Trials (carfilzomib) | Recent Studies (post-2010) (carfilzomib) |
---|---|---|---|---|---|
841 | 185 | 554 | 748 | 121 | 716 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Afzal, M; Al Rikabi, AC; Al-Harbi, MM; Al-Harbi, NO; Al-Shabanah, OA; Alotaibi, MR; As Sobeai, HM; Imam, F; Kazmi, I | 1 |
2 other study(ies) available for olmesartan and carfilzomib
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway.
Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Flavonoids; Imidazoles; Inflammation; Kidney; Male; NF-kappa B; Nitric Oxide Synthase; Oligopeptides; Oxidative Stress; Rats; Rats, Wistar; Rutin; Signal Transduction; Tetrazoles | 2019 |